• Capricor Therapeutics EVP and General Counsel Karen Krasney exercised stock options for 900 shares at USD 3.18 on June 22-24.
• Krasney sold 900 shares at USD 30 on the same dates.
• She ended with 30,547 Capricor common shares directly owned.
• Her stock options holdings fell to 55,361 following the exercises.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capricor Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001593086-26-000010), on June 24, 2026, and is solely responsible for the information contained therein.